Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:10 AM
Ignite Modification Date:
2025-12-26 @ 11:10 AM
NCT ID:
NCT06485128
Eligibility Criteria:
Inclusion Criteria:
* Adult patients with a confirmed or suspect diagnosis of glaucoma based on intra-ocular eye pressure, visual field defect and structural optic nerve changes, regardless their age.
* Adult patients with chronic kidney disease regardless their age.
* Adult patients with heart failure with preserved ejection fraction (HFpEF), regardless their age: symptomatic heart failure with Left Ventricle Ejection Fraction \> 50% AND BNP \> 35 pg/ml (or NT-proBNP\>125 pg/ml) OR signs of diastolic dysfunction according to the European Society of Cardiology guidelines 2016
* Adult patients with confirmed small vessel disease as is diagnosed on routine neurological imaging, regardless their age.
* People without history or track record of any relevant pathology, including cardiovascular and renal diseases, regardless their age
* Capable and willing to participate (informed consent)
Exclusion Criteria:
* Diabetes
* Personal medical history of retinal neovascularization.
* Unable or unwilling to give consent
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06485128
Study Brief:
Protocol Section:
NCT06485128